Trial Profile
Comparison of treatment outcomes with bivalirudin and unfractionated Heparin in patients with non-acute coronary syndromes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2017
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary)
- Indications Coronary disorders; Myocardial infarction
- Focus Adverse reactions
- 14 Jul 2017 New trial record